Info Sheet , Human ADME , Radiosynthesis , Clinical Pharmacology

Human ADME Capabilities

4 January 2022
Overview

With over 30 years’ experience as a world leading provider of human ADME 14C radiolabeled studies, we have the scientific expertise and operational know-how to design and deliver human ADME programs in preparation for NDA, MAA and global regulatory filings.

Download
Date
4 January 2022